Enhancement of T cell proliferative response against autologous cancer cells of a metasatic renal cell carcinomapatient after unexplained regression. セルメディシン株式会社が紹介する自家がんワクチン療法に関する記事や、論文をご覧いただけます。

会社情報

紹介記事・論文

Enhancement of T cell proliferative response against autologous cancer cells of a metasatic renal cell carcinomapatient after unexplained regression.

Authors:Kawai K, Saijo K, Oikawa T, Ohno T, Akaza H.

Journal:Int J Urol. 2004 Dec;11(12):1130-2.

Abstract:The unexplained regression of a metastasis of renal cell carcinoma (RCC) is rare phenomenon. While an immune mechanism has been proposed for spontaneous or unexplained regression of RCC, only limited data are available regarding immunological response. We report a case of a 62-year-old man with RCC whose paravertebral pleural tumor regressed after the withdrawal of interferon-alpha. In the present case, we demonstrate theenhancement of T cell proliferative response against autologous RCC cells secondary to the unexplained regression using the mixed-lymphocyte tumor culture. To our knowledge, the enhancement of an antitumor immunity secondary to an unexplained regression of RCC has not previously been reported.

注:弊社は病院やクリニックではなくバイオ企業であるため、症例報告や論文内容のWeb掲載は許容されています。

ご相談は無料です。
お気軽にお問い合わせください。